Kurv Yield Premium Strategy Microsoft MSFT ETF (MSFY) 시세

CDNS, 10 Q due Monday 4/28
https://investorshub.advfn.com/uimage/uploads/2025/4/27/uvviyIMG_6347.gif

branster As you probably are aware NWBO must adhere to SEC requirements and formally announce within a specified time frame (4-5 days ?) any material event that would affect the company's share price.
MHRA guide lines are irreverent ...

But should you listen to the "Inmates"?

Just wondering.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176058904

https://media.tenor.com/7peTamY9iPoAAAAj/benjammins-don%27t-kill-me.gif

"here are my now concrete proposals to fix things between the U.S. and those countries most of have never stopped thinking of as our friends and allies"

It's a nice thought, but why would they imagine they could trust us past the next election cycle? Our current president has broken

MAIA recent 52 week low
https://investorshub.advfn.com/uimage/uploads/2025/4/27/dxdnsIMG_6346.gif

My favorite apart about iHub and OTC stocks in general is that no one actually reads anything. No research. No logics. No connecting the dots. 🤣😂

It's always the "paid basher's" and "shorter's." That's all it ever is - just excuses. So, they don't have to believe in r

Unfortunately the SEC does not have a specific timeline for SEC registered companies to file Financials or face predictable consequences of Administrative Proceedings to revoke those companies' SEC registration(s).

Years ago I filled out a random SEC survey where I provided numerous e

Fake it to you make it !!!! ------------- Management doesn't seem to have a lot of respect for the shareholders, when was the last time they put out any kind of news and the pps went up?

entire list in previous post https://x.com/_NewsBarron/status/1916475480821113156

Doing a chart review and JAGX showed up as one
of the 'movers'. Got my attention since I sold out before
they cratered on the failed PH 3...

So doing a little digging last night and it appears the
PH 3 had some success in at least one category of cancer.

For the schizo trial: Notably, we haven't gotten an LPLV announcement for Part B yet. This is something to watch for. This is a very small, single site trial, so database lock and analysis should not take long after.

As for AD, I thought the company was still guiding "end of year" for

Lot's of ideas and just outright guesses about where we are in the approval process.

My favorite is the label. Several scenarios of the label review with expanded use and my favorite of those involves a BP with their input for their product.

The recent appearance of so

FOXO .65 cents BY NOON THE 28TH .45- 55 cents close monday ,,, hope it goes the other way and gains traction but not feeling this was the right move ,,,, been in it in several other plays and it destroyed them ,,, again only my opinion hope I am wrong ,,, GLTA

Yes Jammy might be right, we had 4 days of going up of 2 pennies, and if we get news on Percocet, then we can go back down to take out the gap. This has been going on since October 22,2024 with the 3 drugs that Eltp bought, 1 approved Anda, and our biggest winner Vyvanse. So I would expect the same

✅ Agreed Peach,
“ unlike their American counterparts”

Using bagasse in beef cattle diets as a hay substitute COULD BE beneficial in times of low hay inventory.
However, competing on the open market with hay will be difficult given that bagasse would need chemical treatme

WTM - David Wenger and I have corresponded, and I have sent Paul Rodden some of my views as well.

Both of the hydrogen cheerleaders could improve their credibility if they allowed an opposing view occaisionally . Rodden is becoming a bit of a clown.

With 9 out of 10 m

What happens to price now that you’re out? Will-find-out-Monday.

I'm not sure if he's actually been restricted. He didn’t really violate the TOS — looking back, not many of his posts were removed. So saying he’s "restricted" seems to be his own claim. We’ll see.

Either way, a clean board that’s easy for everyone to read is how it should be.